Biosimilars Council Blog
3 FOLLOWERS
The Biosimilars Council works to increase patient access to lifesaving, affordable biosimilar medicines. We strive to create a positive regulatory, reimbursement, political, and policy environment to assure biosimilars thrive, providing billions in savings to patients and the healthcare system.
Biosimilars Council Blog
6d ago
Last week’s Festival of Biologics in San Diego came during a critical time for our industry when unfolding challenges and ..read more
Biosimilars Council Blog
3M ago
Last year’s launch of the first biosimilar of Humira (adalimumab) signified a major opportunity to increase patient access to, and ..read more
Biosimilars Council Blog
1y ago
A recent series in Health Affairs questioned whether competition from biosimilar medicines is a viable path to providing relief from ..read more
Biosimilars Council Blog
1y ago
When it comes to ensuring medicines — including biosimilars — are safe and effective for patients, the FDA remains the ..read more
Biosimilars Council Blog
1y ago
Dr. Sameer Awsare, Internal Medicine Physician and Associate Executive Director at Kaiser Permanente Medical Group, sat down with the Biosimilars ..read more
Biosimilars Council Blog
1y ago
Biosimilar competition has the potential to provide greater access to important treatments for America’s patients and cost savings for the ..read more